These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3293841)

  • 1. In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.
    Dodion P; Sanders C; Georges P; Kenis Y
    Cancer Chemother Pharmacol; 1988; 22(1):80-2. PubMed ID: 3293841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of platinum analogue cytotoxicity by hyperthermia.
    Xu MJ; Alberts DS
    Cancer Chemother Pharmacol; 1988; 21(3):191-6. PubMed ID: 3282706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay.
    Schroyens WA; Meeker JB; Dodion P; Stryckmans PA; Rozencweig M
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1309-12. PubMed ID: 3053206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
    Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
    Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro.
    Harstrick A; Casper J; Guba R; Wilke H; Poliwoda H; Schmoll HJ
    Cancer; 1989 Mar; 63(6):1079-83. PubMed ID: 2645036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
    Hrubisko M; Ujházy V
    Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.
    Müller LJ; Moorer-van Delft CM; Roubos EW; Vermorken JB; Boer HH
    Cancer Res; 1992 Feb; 52(4):963-73. PubMed ID: 1737358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.
    Daidone MG; Silvestrini R; Zaffaroni N; Grignolio E; Landoni F
    Invest New Drugs; 1987; 5(3):245-50. PubMed ID: 3312080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
    Roed H; Vindeløv LL; Christensen IJ; Spang-Thomsen M; Hansen HH
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):247-53. PubMed ID: 2833402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
    Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids.
    Russell J; Adam J; Wheldon TE; Kaye SB
    Cancer Chemother Pharmacol; 1989; 23(2):111-4. PubMed ID: 2535968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
    Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
    Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ; Kelland LR; Harrap KR
    Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of drug sensitivity by successive colony-forming assay].
    Azuma A; Hino M; Hirosawa A; Shimabukuro Z; Aoyama A; Ootsuka M; Matsusaka M; Niitani H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):815-20. PubMed ID: 3032106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
    Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.